Omada Health Submits IPO Filing with SEC
Omada Health files for IPO with SEC, focusing on chronic care management. Revenue growth noted, but net losses persist. 📈💼
Current updates in the epidemiology and comorbidities of atopic dermatitis.
Epidemiology of atopic dermatitis reveals 10-20% prevalence globally, with significant comorbidities like asthma and allergic rhinitis. 🌍🩺
AI’s Role in Addressing Radiology’s Data Challenges
AI aids in managing radiology's data challenges, addressing radiologist shortages and increasing imaging demands. 📊🤖
Innovative, Technology-Driven, Digital Tools for Managing Pediatric Urinary Incontinence: Scoping Review.
Exploring digital tools for pediatric urinary incontinence: 66 studies reveal innovative solutions! 📊💡
Weekly Health & AI Digest – May 12, 2025
Here are the latest breakthroughs in health & AI (May 12, 2025 week) 🔹 AI Model Predicts Pediatric Brain Cancer Relapse with High Accuracy AI predicts pediatric brain cancer relapse with 75-89% accuracy, improving care for children with gliomas. 🧠📈...
AI Model Predicts Pediatric Brain Cancer Relapse with High Accuracy
AI predicts pediatric brain cancer relapse with 75-89% accuracy, improving care for children with gliomas. 🧠📈
Decoding per- and polyfluoroalkyl substances (PFAS) in hepatocellular carcinoma: a multi-omics and computational toxicology approach.
PFAS exposure linked to hepatocellular carcinoma: 6 key genes identified! 🧬🔬 Study reveals molecular mechanisms and potential therapeutic targets.
TSOLife Secures $43 Million in Series B Funding for Senior Living Innovations
TSOLife raises $43 million for its AI platform, Minerva, enhancing senior living through data-driven insights and community connections. 🏡📊